Ikena Oncology, Inc.

NASDAQ:IKNA

1.71 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -68.166-68.765-34.115-44.256-16.817-40.865
Depreciation & Amortization 1.020.7510.5440.30.2430.422
Deferred Income Tax 2.8700000
Stock Based Compensation 7.6327.5255.1771.7971.1690.314
Change In Working Capital -21.669-15.138-33.032-7.77163.4530.058
Accounts Receivables -2.87-0.2910.3610.519-1.3320
Inventory 2.870-0.361-0.5191.3320
Accounts Payables -2.87-0.2910.3610.519-1.3320.602
Other Working Capital -18.799-14.556-33.393-8.2964.785-0.544
Other Non Cash Items -1.431.5181.17412.104-0.12129.019
Operating Cash Flow -79.743-74.109-60.252-37.82647.927-11.608
Investing Activities:
Investments In Property Plant And Equipment -0.414-1.431-1.76-0.766-0.316-0.305
Acquisitions Net 40.0397.85303.688011.274
Purchases Of Investments -90.052-216.3380000
Sales Maturities Of Investments 154.61118.4850000
Other Investing Activites -40.03-97.853-1.7733.688011.274
Investing Cash Flow 64.144-99.284-1.762.922-0.31610.969
Financing Activities:
Debt Repayment 000000
Common Stock Issued 37.5571.095131.302116.18416.3160
Common Stock Repurchased -0.6630-0.146-0.05700
Dividends Paid 000000
Other Financing Activities 39.0861.0950.5820.05700
Financing Cash Flow 75.981.095131.738116.18416.3160
Other Information:
Effect Of Forex Changes On Cash -0.40600000
Net Change In Cash 59.975-172.29869.72681.2863.927-0.639
Cash At End Of Period 119.89460.791233.089163.36382.08318.156